MIRA
NASDAQ · Pharmaceuticals
Mira Pharmaceuticals Inc
$0.87
+0.04 (+5.06%)
Open$0.83
Previous Close$0.83
Day High$0.90
Day Low$0.80
52W High$2.45
52W Low$0.60
Volume—
Avg Volume176.7K
Market Cap34.97M
P/E Ratio—
EPS$-0.32
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+2,533.8% upside
Current
$0.87
$0.87
Target
$23.03
$23.03
$12.17
$23.03 avg
$29.15
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 15.23M | 13.68M | 17.07M |
| Net Income | 2.05M | 2.22M | 2.28M |
| Profit Margin | 13.5% | 16.2% | 13.3% |
| EBITDA | 4.17M | 3.79M | 4.72M |
| Free Cash Flow | 3.12M | 1.71M | 2.33M |
| Rev Growth | +3.2% | +10.2% | +2.3% |
| Debt/Equity | 0.43 | 0.37 | 0.36 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |